胶质瘤术后重返工作的患者中心结局分析
本研究回顾性分析2012至2018年接受手术的58例WHO II–III级胶质瘤患者的神经肿瘤学与功能结局,并通过问卷评估疾病对职业状态、社会经济状况及神经认知功能的影响。中位随访43.8个月后,41例(70.7%)患者能够重返工作,中位重返工作时间为8.0个月;多因素回归显示年龄<40岁、职业类别及自述疲劳与重返工作独立相关。作者认为重返职业是脑肿瘤术后重要的患者导向结局指标,保留神经功能对患者生活质量至关重要。
要点
- 多数胶质瘤患者术后经手术及辅助治疗可重返工作
- 手术时年龄<40岁与更高重返工作概率相关
- 保留神经功能对患者个体生活质量极为重要
核心结论
- 胶质瘤术后重返职业活动是重要的患者导向结局参数,多数患者经手术与辅助治疗能重返工作。
- 保留神经功能对患者个体生活质量具有最高相关性。
研究设计与样本
- 评估2012至2018年间接受手术的WHO II级和III级胶质瘤患者的神经肿瘤学与功能结局。
- 治疗与生存参数前瞻性收集,疾病对职业状态、社会经济状况及神经认知功能的影响通过问卷回顾性评估。
- 共分析58例胶质瘤患者数据(WHO II级9例,III级49例)。
主要发现
- 中位患者年龄35.8岁(范围21–63岁)。
- 32例(55.2%)采用清醒手术技术。
- 全切除33例(56.9%),次全切除17例(29.3%),部分切除8例(13.8%)。
- 46例(79.3%)接受辅助治疗,中位随访43.8个月(范围11–82个月)。
- 治疗后41例(70.7%)能够重返工作,中位重返工作时间8.0个月(范围0.2–22.0个月)。
关键数值与推荐
- 重返工作定义为治疗后恢复职业活动,本组比例为41/58(70.7%)。
- 中位重返工作时间8.0个月(范围0.2–22.0个月)。
- 年龄<40岁与重返工作概率相关,p < .001。
临床怎么用
- 在胶质瘤患者术后评估与咨询中,可将重返工作作为患者导向结局指标进行关注。
- 对年龄<40岁、职业类别及自述疲劳等因素加以评估,有助于判断重返工作的可能性。
- 手术中应重视保留神经功能,以维护患者生活质量。
局限性
- 为单中心回顾性问卷评估职业与社会经济结局,样本量58例。
- 仅纳入WHO II级和III级胶质瘤患者,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With refinements in diagnosis and therapy of gliomas, the importance of survival time as the sole outcome parameter has decreased, and patient-centered outcome parameters have gained interest. Pursuing a profession is an indispensable component of human happiness. The aim of this study was to analyze the professional outcomes besides their neuro-oncological and functional evaluation after surgery for gliomas in eloquent areas. METHODS: We assessed neuro-oncological and functional outcomes of patients with gliomas WHO grades II and III undergoing surgery between 2012 and 2018. All patients underwent routine follow-up and adjuvant treatment. Treatment and survival parameters were collected prospectively. Repercussions of the disease on the patients' professional status, socio-economic situation, and neurocognitive function were evaluated retrospectively with questionnaires. RESULTS: We analyzed data of 58 patients with gliomas (WHO II: 9; III: 49). Median patient age was 35.8 years (range 21-63 years). Awake surgery techniques were applied in 32 patients (55.2%). Gross total and subtotal tumor resections were achieved in 33 (56.9%) and 17 (29.3%) patients, respectively, whereas in 8 patients (13.8%) resection had to remain partial. Most patients (n = 46; 79.3%) received adjuvant treatment. Median follow up was 43.8 months (range 11-82 months). After treatment 41 patients (70.7%) were able to resume a working life. Median time until returning to work was 8.0 months (range 0.2-22.0 months). To be younger than 40 at the time of the surgery was associated with a higher probability to return to work (p < .001). Multivariable regression analysis showed that patient age < 40 years as well as occupational group and self-reported fatigue were factors independently associated with the ability to return to work. CONCLUSION: The ability to resume professional activities following brain tumor surgery is an important patient-oriented outcome parameter. We found that the majority of patients with gliomas were able to return to work following surgical and adjuvant treatment. Preservation of neurological function is of utmost relevance for individual patients´ quality of life.
引用
- Senft C, Behrens M, Lortz I, et al. The ability to return to work: a patient-centered outcome parameter following glioma surgery. J Neurooncol. 2020. PMID: 32960402. doi:10.1007/s11060-020-03609-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。